L-Phenylglycine amide hydrochloride

L-Phenylglycine amide hydrochloride is an L-configured phenylglycine derivative in which the amino acid carboxyl functionality is converted to an amide, while the amino functionality is present as a hydrochloride salt to support handling and controlled reactivity. The molecule contains a chiral center at the phenylglycine backbone, an anilide-like aromatic substituent, and a terminal protonated amine salt form that influences solubility and coupling behavior. The amide carbonyl provides a stable linkage for downstream transformations, while the salt-associated amine can participate in peptide-coupling chemistries after appropriate base-mediated neutralization. As a chiral amino acid derivative intermediate, it can be integrated into peptide building block preparation, side-chain functionalization sequences, and chiral auxiliary or fragment-based synthetic routes that require stereodefined phenylglycine motifs.

1. Peptide Coupling Chemistry

L-Phenylglycine amide hydrochloride is applied in peptide synthesis workflows where a phenylglycine stereocenter and an amide-containing backbone fragment are required for amide bond construction. The hydrochloride salt form helps manage the amino function during derivatization, and the pre-installed amide carbonyl can be carried through coupling steps as a protected or built-in linkage depending on the target sequence design. Neutralization and activation strategies can enable incorporation into peptide-like structures via standard amide-forming chemistry, supporting the preparation of dipeptide and peptidomimetic segments. Downstream, the resulting stereodefined amide fragment can be used to assemble longer chains for structure-activity relationship studies and sequence optimization in synthetic peptide libraries.

2. Peptidomimetics And SAR Studies

L-Phenylglycine amide hydrochloride supports peptidomimetic construction for structure-activity relationship studies that require conformationally informative benzyl-substituted glycine analogs. The phenyl group on the side chain and the L-configuration at the backbone provide a stereochemically defined scaffold that can modulate binding interactions when embedded into amide-rich analogs. The amide functionality allows controlled elaboration into additional carbonyl-containing motifs, enabling systematic variation of chain length, hydrogen-bonding patterns, and aromatic exposure. The compound can therefore serve as a chiral fragment for generating focused SAR panels of phenylglycine-containing analogs used in biochemical research and molecular design programs.

3. Chiral Building Block Synthesis

L-Phenylglycine amide hydrochloride is utilized as a chiral amino acid intermediate in stereoselective synthetic organic chemistry where phenylglycine-derived fragments must be introduced with defined configuration. The L-stereocenter adjacent to the aromatic substituent provides a stereochemical handle that can be retained through subsequent functional group manipulations, including N-substitution, carbonyl activation, and further derivatization of the amide-linked framework. The hydrochloride salt form can be advantageous for reproducible handling in chiral synthesis, particularly when preparing downstream activated intermediates for coupling or for conversion into alternative protected forms. The resulting intermediates can be employed to build chiral libraries, generate enantiomerically consistent reference compounds, and support fragment-based molecular design efforts.

4. Chemical Biology Labeling Precursors

L-Phenylglycine amide hydrochloride can be applied as a chemical biology intermediate for preparing labeled or functionalized phenylglycine-containing probes. The amide carbonyl and aromatic side chain can be integrated into probe scaffolds that rely on stable amide linkages and defined stereochemistry for predictable binding or recognition behavior. The hydrochloride salt enables controlled formation of reactive derivatives after base treatment, supporting conjugation strategies such as attachment to activated esters, linker-bearing electrophiles, or coupling partners used in biomolecule modification. Downstream, the compound-derived fragments can be incorporated into affinity tags, tracer molecules, and analytical standards that probe peptide recognition, substrate specificity, or ligand binding in biochemical assays.

5. Pharmaceutical Intermediate Preparation

L-Phenylglycine amide hydrochloride is suitable for pharmaceutical intermediate preparation where chiral phenylglycine amide motifs are incorporated into drug-like scaffolds and process-relevant intermediates. The stable amide group and the stereogenic center adjacent to the aromatic substituent allow the compound to function as a defined building block for constructing amide-rich structures common in medicinal chemistry. The salt form can facilitate controlled solubilization and handling during intermediate transformations, supporting scalable synthesis planning that converts the amino functionality into coupling-ready forms when required. The compound can thus feed into downstream fine chemical synthesis routes that generate stereodefined intermediates for peptide-like drug candidates and peptidomimetic lead optimization programs.

6. Process Chemistry For Fine Chemicals

L-Phenylglycine amide hydrochloride is used in process chemistry contexts to prepare chiral, amide-containing intermediates for specialty chemical production. The combination of an L-configured backbone and an amide carbonyl supports predictable downstream behavior during activation, N-functionalization, and sequential assembly of larger molecules. The hydrochloride salt form can be leveraged for consistent material handling and for tuning reactivity during controlled conversion to coupling partners or protected derivative forms. The resulting phenylglycine-derived intermediates can be employed across manufacturing-oriented synthetic sequences that require stereochemical integrity and amide compatibility, including industrial-scale preparation of peptide analogs and chiral building blocks for applied research and development.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy